This finding indicates that the statin-induced reduction in androgen levels is at least partially due to the inhibition of isoprenylation, resulting in a decreased expression of CYP17A1, especially in PCOS, where this enzyme is prominent [124]. The gene discussed is CYP17A1; the disease is polycystic ovary syndrome.